» Articles » PMID: 38966083

Causal Relationship of Interferon-γ and Interleukin-18 Upstream of Intervertebral Disc Degeneration Pathogenesis: a Two-sample Mendelian Randomization Study

Overview
Journal Front Neurol
Specialty Neurology
Date 2024 Jul 5
PMID 38966083
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Intervertebral disc degeneration (IVDD) is a complex disease caused by genetic and environmental factors, but its pathogenesis is still unclear. Although studies of inflammatory cytokines have been used in recent years to unravel the biological mechanisms of a variety of diseases, such analyses have not yet been applied to IVDD. Therefore, we used a Mendelian Randomization approach to explore the potential mechanisms underlying the pathogenesis of IVDD.

Methods: We obtained GWAS data from publicly available databases for inflammatory cytokines and IVDD, respectively, and explored the causal relationship between individual inflammatory cytokines and IVDD using instrumental variable (IV) analysis. We primarily used IVW methods to assess causality, while sensitivity, heterogeneity and multidirectionality analyses were performed for positive results ( < 0.05). All analyses were performed using R software.

Results: In our study, we performed a two-sample MR analysis of 41 inflammatory cytokines to identify metabolites causally associated with IVDD. Ultimately, 2 serum metabolites associated with IVDD were identified (pval<0.05), IFN-γ and IL-18. sensitivity, heterogeneity, and Pleiotropy test analyses were performed for all results.

Conclusion: Our study identified a causal relationship between IFN-γ and IL-18 and IVDD. It is valuable for the monitoring and prevention of IVDD and the exploration of targeted drugs. However, more evidence is needed to validate our study.

References
1.
Han Y, Li X, Yan M, Yang M, Wang S, Pan J . Oxidative damage induces apoptosis and promotes calcification in disc cartilage endplate cell through ROS/MAPK/NF-κB pathway: Implications for disc degeneration. Biochem Biophys Res Commun. 2017; 516(3):1026-1032. DOI: 10.1016/j.bbrc.2017.03.111. View

2.
Davies N, Holmes M, Davey Smith G . Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018; 362:k601. PMC: 6041728. DOI: 10.1136/bmj.k601. View

3.
Hou X, Shen Y, Sun M, Zhang B, Dai J, Chen D . Effect of regulating macrophage polarization phenotype on intervertebral disc degeneration. Immun Inflamm Dis. 2022; 10(11):e714. PMC: 9609449. DOI: 10.1002/iid3.714. View

4.
Burgess S, Small D, Thompson S . A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2015; 26(5):2333-2355. PMC: 5642006. DOI: 10.1177/0962280215597579. View

5.
Larsson S, Butterworth A, Burgess S . Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023; 44(47):4913-4924. PMC: 10719501. DOI: 10.1093/eurheartj/ehad736. View